Connect with us

Business

Diego Pellicer Worldwide Inc. (OTCMKTS:DPWW) Announces 8.56% Growth In Sales For Denver Licensee

Published

on

Diego Pellicer Worldwide Inc. (OTCMKTS:DPWW) has announced that in July its Denver Licensee reported exceptional sales along with an 8.56% increase in average tickets sales from April which has given an edge in the market.

Diego Pellicer Worldwide leveraging the craft cannabis segment

Ron Throgmartin the CEO of Diego Pellicer Worldwide stated that Diego Pellicer-Colorado has demonstrated that having premium products, good customer service as well as offering world-class shopping experience can be the difference towards realizing success. Throgmartin said that craft cannabis, for instance, is big news in the industry currently but Diego Pellicer-Colorado has been working hard to ensure they curate and make it accessible at all prices. This has been vital to the company and has helped deliver its premium promises of expanding its customer base.

The CEO shared his insight on craft cannabis in the August 2019 Marijuana Business Magazine. He also shares the vertical integration strategies the company is taking as well as an understanding of the retail cannabis environment. Throgmartin indicates that’s that they are considering becoming vertically integrated to a point the company has some ceiling on pricing, quality, and availability but not to the extent of compromising the company’s promise to its customers of producing the best product for them.

Growing opportunities in Colorado

Colorado presents numerous opportunities to the company following the signing into law House Bill 1090 by Governor Polis in May 2019. The public Company law which will be effective from November this year permits public companies in Colorado to own cannabis licenses. According to the CEO, for the company to grow it has to take necessary steps in ownership and operations in cannabis as well as branded marijuana products that will be offered in their retail locations and company stores.

The cannabis brand and the retail company seeks to elevate the shopping experience of cannabis regardless of the location of the customer. The company is developing and managing high-end cannabis retail stores and cannabis products. The company has already positioned itself as a vertically integrated cannabis company to take full advantage of the market once marijuana is federally legalized.

Business

Why ISWH May Be a Prime Turnaround Opportunity in the Making

Published

on

For those in search of speculative turnaround potential in the small and micro-cap market space, you could do a whole lot worse than International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH). The big picture here is a diversified branding play with commercial-stage operations already in place in the CBD, Wellness, Home Healthcare, and Spirits industries, and development stage operations in the Renewable Energy and Supply Chain & Logistics markets.

Based on recent financial performance, the company may have recently gotten past the point where its operational cash flows can start to fully support its future growth investments. For any micro-cap, this is the golden point in the investment cycle: when growth becomes non-dilutive. ISWH is either at or very near this point, posting EBITDA profitability and triple-digit topline growth in Q3 and Q4 of 2019.

ISWH recently completed a shareholder-friendly restructuring and reverse stock split to better align its price-per-share quote with common standards for investor perception.

Pro-tip: In our experience, when a company has this much going for it, and then does this type of restructuring and realignment, it’s typically in front of a lot of major positive news. The shift in structure and share price is to set the stage so that the company’s existing long-term shareholders can get the most bang for the buck on new strong announcements set to roll out over coming weeks and months.

In other words, the stage is set for some big happy news for ISWH. Take note.

In the words of the company’s President and Chairman, Alonzo Pierce: “A shareholder-friendly restructuring was necessary to strengthen our relationship with capital markets, pursue a near-term uplist to a higher exchange tier, and set in motion our operational strategy for 2020. We have a number of very compelling catalysts set to roll out, but we needed to provide a viable context – to lay a foundation for that success – as an initial step. We have achieved that with our restructuring and reverse split last week.”

That just about says it all.

The Foundation

The foundation for ISWH right now is its two main commercial-stage growth drivers: CBD-based products and the company’s rapidly growing home healthcare business.

The CBD products segment is positioned for rapidly accelerating growth this year following the signing of its defining partnership agreement with BioPulse Labs, a nationally-recognized brand development and manufacturing leader in the nano-infusion of CBD products. The BioPulse agreement provides for effectively a starter package in product development and marketing for the fresh launch of five new CBD-based wellness products. That will effectively push a restart button for the company’s P19 brand of CBD-based products.

The company also has an edge through this partnership due to the fact that it will be that rare CBD products brand able to boast that all of its products are formulated and produced in FDA compliant and registered facilities. This is becoming a huge issue in the current world of garage-band CBD producers. Consumers don’t know what they’re getting when they purchase CBD products. And they’re starting to figure that out.

The Home Healthcare segment is rapidly expanding as well. This division saw quadruple-digit percentage growth during the back half of 2019, and the company has implied that this trend is set to continue in Q1 2020.

Home healthcare spending is expected to reach more than $186 billion in 2027, according to a recent analysis from the Centers for Medicare & Medicaid Services (CMS) Office of the Actuary. This vastly surpasses any other category of health care service spending, even including hospital inpatient care, physician and professional services, nursing facilities, prescription drugs, retail sales of medical products and anything else you can think of.

ISWH has put in place a strong operational footprint in this rapidly expanding market, and we would look for continued strong performance throughout 2020.

Conclusion

With this foundation in place, a possible inflection toward non-dilutive growth in the quarters ahead, and now standing on the other side of the company’s recent shareholder-friendly restructuring, ISWH is an extremely interesting speculative opportunity, especially given our assumption that the company is getting ready to add some very strong new catalysts into the mix in coming weeks.

ISWH management drove this same sense home in its latest release: “This is truly all about embracing a very aggressive growth-oriented future path at ISWH,” continued Pierce. “We have put in place a winning framework as a genuine disruptor in the health and wellness space, and we continue to see dramatic growth in that endeavor, including strong financial performance over recent quarters. We are also entering several new markets, with a true edge already in place, and will be providing details on those strategic moves over the very near term. Long story short: we have some very exciting announcements ahead and we wanted to provide a solid structural foundation in the stock ahead of those catalysts for the benefit of our committed shareholders.”

Continue Reading

Business

ANVISA Authorizes Khiron Life Sciences Corp (OTCMKTS:KHRNF) To Import Medical Cannabis Products Into Brazil From Colombia

Published

on

Brazilian Health Regulatory Agency (ANVISA) has authorized Khiron Life Sciences Corp (OTCMKTS:KHRNF) to import medical cannabis products on an individual patient basis. Khiron can now apply for a license to export medical cannabis products to Brazil with this authorization. The company also needs the nod of TSX for the commercialization of cannabis in Brazil.

Khiron achieves a milestone

Director and Chief Executive Officer of Khiron, Alvaro Torres, said the company achieved another milestone on receiving the regulatory nod from ANVISA to introduce its medical cannabis products in the largest Latin American market. It allows the company to serve the patient population in that region. He further said Khiron work towards achieving authorizations in Peru and Colombia and improves its network in Brazil.

A regulatory framework to import medical cannabis

ANVISA has established a regulatory framework that involves a comprehensive procedure for the production and importing the medical cannabis products into Brazil. The medical cannabis products are prescribed by the physicians and marketed through pharmacies. Therefore, patients get safe access to legal medical cannabis products.  Cannabis is beneficial for regulating oily skin and helps to fight aging.

The market for medical cannabis

The demand for medical cannabis in Brazil expects to reach 1.4 billion in the next three years. Also, the patient base that comprises patients with chronic conditions in Brazil will increase to 3.4 million. The request for medical cannabis products in the nation almost tripled since 2015. Around 1,100 physicians are prescribing medical cannabis products to the patients.

Chairman of Khiron resigns

Sidney Himmel, chairman of Khiron, has resigned to pursue other interests. Following his resignation, Alvaro will act as interim chairman of the company. Deborah Rosati will head the audit committee.

Khiron formed a JV with Dixie Brands to focus on the development of cannabis products. As per the terms of the pact, Dixie will also engage in the manufacture and distribution of kuida brand CBD cosmeceuticals targeting Hispanic population in the US. The joint venture with Dixie Brands gives Khiron exposure to the US market.

Chris Naprawa is a president at Khiron. Before joining Khiron, he worked as MD at Primary Capital and as a partner at Sprott Capital Partners.

Continue Reading

Business

Cannabis Control Commission Grants License To Curaleaf Holdings Inc (OTCMKTS:CURLF) To Inaugurate Retail Dispensary In Massachusetts

Published

on

Massachusetts Cannabis Control Commission has granted final license approval to Curaleaf Holdings Inc (OTCMKTS:CURLF) to inaugurate an adult-use cannabis dispensary at 124 Street in Ware, Massachusetts. The company expects to schedule the post-final inspections to inaugurate adult-use location by early March this year.

Opened first adult-use location in November 2019

Curaleaf has inaugurated its adult-use retail cannabis location in November 2019 in Oxford, Massachusetts. On January 29, 2020, the company opened the second adult-use location in Provincetown. It also established medical use cannabis facility in Hanover.

Reliable and high-quality medical use products

Chief Executive Officer of Curaleaf, Joseph Lusardi, said the company’s main strategy is to provide reliable and high-quality medical use cannabis products to the customers and patients in Massachusetts. The company is pleased to open a third adult-use retail cannabis dispensary in the commonwealth of Massachusetts.

Adds twenty new jobs

Patrick Jansson, President of Curaleaf Massachusetts, said the company will add twenty new jobs and contribute to the local economy. It yearns to establish a positive and impactful relationship with the local community. The company is pleased to bring its business to the Ware, Hampshire County. Curaleaf operates 53 dispensaries in the US.

Announces Expiration of waiting period for Grassroots

Curaleaf said the waiting period under the HSR (Hart-Scott-Rodino Antitrust Improvements Act of 1976) has expired to take over GR Companies, Inc. (“Grassroots”). Both the firms will work together to obtain state and regulatory approvals and complete the transaction in spring 2020.

Joseph said the company is excited to achieve milestones because it strives to acquire Grassroots. Following the takeover, Curaleaf expects to establish a strong presence in the Midwest. The customers and patients can get access to its industry-leading brands. Curaleaf will continue to focus on executing its strategy and enjoy the benefits of brand recognition and greater scale in the new and existing markets.

Grassroots is engaged in the sale of reliable cannabis products that improve the lives of people from all backgrounds. The customers can enjoy a unique, education, and wellness-focused dispensary experience. It holds facilities in Maryland, Michigan, Vermont, Ohio, Oklahoma, Pennsylvania, Nevada, Illinois, Connecticut, Arkansas, and North Dakota.

Continue Reading

FEATURED STORIES

Business5 hours ago

Why ISWH May Be a Prime Turnaround Opportunity in the Making

Post Views: 46 For those in search of speculative turnaround potential in the small and micro-cap market space, you could...

Business23 hours ago

ANVISA Authorizes Khiron Life Sciences Corp (OTCMKTS:KHRNF) To Import Medical Cannabis Products Into Brazil From Colombia

Post Views: 217 Brazilian Health Regulatory Agency (ANVISA) has authorized Khiron Life Sciences Corp (OTCMKTS:KHRNF) to import medical cannabis products...

Business4 days ago

Cannabis Control Commission Grants License To Curaleaf Holdings Inc (OTCMKTS:CURLF) To Inaugurate Retail Dispensary In Massachusetts

Post Views: 224 Massachusetts Cannabis Control Commission has granted final license approval to Curaleaf Holdings Inc (OTCMKTS:CURLF) to inaugurate an...

Business5 days ago

Starseed Medicinal Inc, A Subsidiary Of WeedMD Inc (OTCMKTS:WDDMF), Becomes A Preferred Supplier Of Medical Cannabis To myHSA Program Participants In Canada

Post Views: 153 Starseed Medicinal Inc, a subsidiary of WeedMD Inc (OTCMKTS:WDDMF), has become a preferred supplier of medical cannabis...

Business6 days ago

Innovative Industrial Properties Inc (NYSE:IIPR) Acquires Toledo, Ohio processing facility And Leases Back To Green Thumb Industries Inc (OTCMKTS:GTBIF)

Post Views: 209 Innovative Industrial Properties Inc (NYSE:IIPR) has acquired Toledo, Ohio processing facility from Green Thumb Industries Inc (OTCMKTS:GTBIF)...

Business7 days ago

NewLeaf Brands Inc (OTCMKTS:NLBIF) Signs An LOI To Take Over 37.5% Stake In Trellis Holdings Oregon Op LLC

Post Views: 138 NewLeaf Brands Inc (OTCMKTS:NLBIF) has signed a letter of intent on February 4, 2020, to acquire a...

Whats Hot